Fig. 6

Panel a and b shows that overweight/ Class 1 obese males had the longest overall survival (OS) among patients treated with monotherapy (a) and combination (b). Panel c and d shows that overweight/Class 1 obese patients with serum creatinine >â=â0.9âmg/dL had the longest OS among patients treated with monotherapy (c) and combination (d)